Water → HCID 58119369, compound

HRID 1187443Notes

Reaction equation

HRID 1187443 reaction equation
[F:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[O:9][CH:10]=[C:11]([CH:13]3[CH2:18][CH2:17][NH:16][CH2:15][CH2:14]3)[N:12]=2)=[CH:4][CH:3]=1.CCN(C(C)C)C(C)C.[CH3:28][S:29](Cl)(=[O:31])=[O:30].O>C(Cl)Cl>[F:1][C:2]1[CH:7]=[CH:6][C:5]([C:8]2[O:9][CH:10]=[C:11]([CH:13]3[CH2:18][CH2:17][N:16]([S:29]([CH3:28])(=[O:31])=[O:30])[CH2:15][CH2:14]3)[N:12]=2)=[CH:4][CH:3]=1

Participants

6

Procedure

To a solution of 4-[2-(4-fluorophenyl)-1,3-oxazol-4-yl]piperidine (220 mg, 0.90 mmol) in DCM (20 mL) was treated with DIEA (0.31 mL, 1.8 mmol) and allowed to stir at rt for 15 min. Methanesulfonyl chloride (0.2 mL, 2.7 mmol) was slowly added to the solution and the resulting mixture was stirred at rt for 2 hr. Upon completion of the reaction, DCM (20 mL) and water (40 mL) was added to the mixture and the two layers were partitioned. The organic layer was dried with MgSO4, filtered and concentrated. The residue was purified by reverse phase HPLC to afford the title compound (100 mg). LC/MS: m/e 325.2 (M+H)+.

Workup

  1. stirringthe resulting mixture was stirred at rt for 2 hr
  2. additionwas added to the mixture
  3. customthe two layers were partitioned
  4. dry with materialThe organic layer was dried with MgSO4
  5. filtrationfiltered
  6. concentrationconcentrated
  7. customThe residue was purified by reverse phase HPLC

Sources & evidence

ORD record
ord-6b713b191b6a49e495c3a06e8bb5117c
Source dataset
uspto-grants-2014_03
Patent number
US08673941B2

Reaction notes

Loading…